Click the document image to open the full study
Short-term healing metrics (wound margin advance and % area reduction over 4 weeks) in a self-controlled model showed that adding neuromuscular stimulation to compression roughly doubled healing rate vs compression alone.
Case report: adding the geko™ NMES device to standard care led to 83.6% wound area reduction in 12 weeks and improved mobility.
46-year-old with hard-to-heal ulcer: NMES 12 h/day reduced pain from 9/10 to 3/10 in a week; full healing by 6 weeks.
High-BMI patient with long-standing VLU: NMES 12 h/day with standard care reduced wound size markedly and achieved full closure by 8 weeks.
Complex mixed-aetiology and neuro-ischaemic wounds: ~50% size reduction at 12 weeks, less pain, better engagement using daily NMES adjunct.
Five chronic VLUs refractory to compression: daily NMES produced full closure in all cases within 4–8 weeks; pain reduction reported; no AEs.
60-patient study: NMES group had less swelling/pain at 48–72 h, higher comfort, and shorter pre-op wait; well tolerated, no adverse effects.
78-year-old with chronic lower-leg wound: pain relief within 24 h and dramatic area reduction over 10 weeks with NMES adjunct.
9-patient evaluation: 8/9 fully healed (many within 2–12 weeks) and the remaining case improved; users reported ease of use and pain reduction.
Evidence that NMES of the common peroneal nerve improves calf pump, venous return and microcirculation; RCT shows faster healing with compression+MPA vs compression alone.
Economic model from an RCT: +68% healing probability vs SoC, with ~£774 per-patient savings and potential 15% NHS wound-care cost reduction.
60-year-old with 5-month non-healing ulcer: daily NMES + compression/dressings produced granulation by week 4 and full healing by week 12.
